Point-of-Care Market Research Reports & Industry Analysis
This value added aspect of POC testing will become even more essential as the menu for POC tests expands with the availability of more tests for cancer and cardiovascular diseases. These test results are more complex and need the support of professional guidance.
In the meantime, investments in high technology made during the 1990s will begin to find commercial appeal in the next five years and will spawn a new genre of POC diagnostic tests and devices. These technological advances will interact with a number of enabling healthcare delivery trends to change the face of clinical diagnostics and the economics of healthcare in general.
Industry professionals anticipate that patient self-testing will skyrocket because of rising consumer expectations, technological innovations, and the surge of consumer activism in healthcare. Further pharmacies, retail outlets and the physician office are establishing their position for patient wellness screening. As the cost of POC devices becomes more affordable and healthcare organizations have constructed data management infrastructures, point-of-care testing has also become an attractive operational and economical alternative to traditional laboratory-based testing in a variety of situations, including physician office testing, home care and in-hospital care.
Point-of-Care Industry Research & Market Reports
-
2023 Global Forecast for Intensive care/coronary care units, including component modules such as temperature, blood pressure (2024-2029 Outlook)-Manufacturing & Markets Report
... on the market for over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2019 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product ... Read More
-
Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Bacteriology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in ... Read More
-
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products with comparative analysis of the products at various ... Read More
-
Asia Pacific Point-of-Care Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product & Services (Assays & Kits, Instruments, and Services & Software), Technology [PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and Other Technologies], Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
... and Other Technologies], Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others) According to our new research study on ... Read More
-
Helicobacter Pylori Testing Market Analysis And Forecast To 2031: By Test (Invasive, Non-Invasive), By Method (Point-of-Care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), And Region
... was valued at USD 436.0 Million in 2021 and it is anticipated to grow up to USD 915.4 Million by 2031, at a CAGR of 7.7% during the forecast period. Helicobacter pylori testing is a ... Read More
-
Europe Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)
... User (Hospitals, Clinics, and Diagnostic Laboratories) The helicobacter pylori (H. pylori) non-invasive testing market in Europe is expected to grow from US$ 198.40 million in 2022 to US$ 244.01 million by 2028; it is estimated ... Read More
-
Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)
... End User (Hospitals, Clinics, and Diagnostic Laboratories) The helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific is expected to grow from US$ 143.04 million in 2022 to US$ 201.37 million by 2028; it ... Read More
-
North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)
... End User (Hospitals, Clinics, and Diagnostic Laboratories) The helicobacter pylori (H. pylori) non-invasive testing market in North America is expected to grow from US$ 211.77 million in 2022 to US$ 265.21 million by 2028; it ... Read More
-
Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)
... Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories) The helicobacter pylori (H. pylori) non-invasive testing market in Middle East & Africa is expected to grow from US$ 39.86 million in 2022 to US$ 54.80 ... Read More
-
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)
... Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories) The helicobacter pylori (H. pylori) non-invasive testing market in South & Central America is expected to grow from US$ 26.14 million in 2022 to US$ 34.64 ... Read More
-
Helicobacter Pylori Testing Market Size By Test (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}, By Method (Point-of-Care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 The global helicobacter pylori testing market is likely to witness considerable growth through 2032, owing ... Read More
-
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025
... emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as significant drivers of the cTn diagnostics market. Hospitals and clinical laboratories adopt ... Read More
-
Point-of-Care Medical Imaging Market Size, Share & Trends Analysis Report By Product (X-ray, Ultrasound, CT), By Application (General, Cardiovascular), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global point-of-care medical imaging market size is anticipated to reach USD 1.67 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing Market Analysis And Forecast To 2031: By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomic Testing, Skincare Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) chips, Whole Genome Sequencing (WGS)), By Distribution Channel (Online Platforms, Over-the-Counter), And Region
... Genome Sequencing (WGS)), By Distribution Channel (Online Platforms, Over-the-Counter), And Region The global direct-to-consumer (DTC) genetic testing market was valued at USD 1.4 Billion in 2021 and it is anticipated to grow up to USD ... Read More
-
Global Sexually Transmitted Diseases (STD) Testing Market Size study & Forecast, by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), and Other Diseases) and Location of Testing (Laboratory Testing, and Point-of-care (POC) Testing) and Regional Analysis, 2022-2029
... Testing, and Point-of-care (POC) Testing) and Regional Analysis, 2022-2029 Global Sexually Transmitted Diseases (STD) Testing Market is valued approximately USD 96.06 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
COVID-19 Rapid Test Kits Global Market Opportunities And Strategies To 2031
... the critical information they need to assess the global COVID-19 rapid test kits market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report ... Read More
-
Point-of-Care Data Management Software Market Research Report 2022-2030
... change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Point-of-Care Data Management Software market size will reach USD million ... Read More
-
IVD Trends and Market Update: November 2022
... of 2022? How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022? What Product Trends and New Developments Will Shape the IVD Market in the last half ... Read More
-
Middle East & Africa In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... is expected to reach USD 5,113.25 million by 2027, registering a CAGR of 4.44% during the forecast period. The COVID-19 pandemic positively impacted the in-vitro diagnostics market since there was an increasing demand for IVD ... Read More
-
Gulf Cooperation Council (GCC) In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... forecast period. The in-vitro diagnostics market saw a boost during the COVID-19 pandemic. For instance, a research article titled "Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-center retrospective study" published in Cardiovascular ... Read More
-
Canada In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the SARS-CoV-2 virus has increased lab testing demands to keep pace with suspected cases of COVID-19. Thus, the recent outbreak of COVID-19 has had a positive impact on the in-vitro diagnostics industry, as it involves ... Read More
-
South Korea In Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... witness a revenue of USD 2,319.15 million in 2027, with a CAGR of 5.42% over the forecast period, 2022-2027. The market studied has observed a positive impact of COVID-19 with the rising number of COVID-19 ... Read More
-
Europe In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... fueling the market include a rapid increase in chronic diseases, increasing demand for point-of-care testing and personalized medicine, and technological advances, along with the rising geriatric population in the region. COVID-19 has a positive impact ... Read More
-
Cardiac PoC Testing Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... COVID-19 pandemic has significantly impacted the manufacturing and distribution of cardiac POC testing devices. In addition, the reduction in cardiovascular disease testing due to the measures related to COVID-19 has adversely affected the cardiac POC ... Read More
-
Australia In-vitro Diagnostics Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
... COVID, the country's conditions were under control. The administration kept its limitations on travel in place. The Australian Health Protection Principal Committee (AHPPC) highly advised wearing masks indoors, especially in situations where physical separation is ... Read More
Research Assistance
